LV RECONSTRUCTION AND TREATMENT OF CARDIOMYOPATHIES

Tuesday, February 28, 2023

9:30 AM – 10:42 AM ET

Moderator(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure(s): Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)
Farooq Sheikh, MD

Medical Director, Advanced Heart Failure Program
MedStar Health, Georgetown University School of Medicine
Washington, District of Columbia, United States

Disclosure(s): Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Disclosure(s):

William T. Abraham, MD: Boehringer Ingelheim: Committee/Planning Member (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); V-WAVE Medical: Salary (Ongoing), Stock-privately held company (Ongoing); Zoll Respicardia: Advisor (Ongoing)

Farooq Sheikh, MD: Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker for educational conference (Ongoing); Alnylam: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ionis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)